Stock listing

Urogen Pharma Ltd.

Selected listing: UR8 · DUS · EUR · DE

Urogen Pharma Ltd. (Dusseldorf:UR8), Health Technology. Latest release Aug 20, 2026: IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration…

UR8:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:UR8
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Dusseldorf
Currency: EUR

Latest news from Urogen Pharma Ltd.

IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies

August 20, 2026

UroGen Announces Strategic Collaboration and Investment Agreements with IntraGel to Access Biodegradable Sustained-Release Gel Platform and Expand Oncology Pipeline

August 20, 2026

UroGen Submits NDA for UGN-103, an Investigational Treatment of Recurrent LG-IR-NMIBC

August 17, 2026

UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights

August 5, 2026

UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026

July 29, 2026

All Urogen Pharma Ltd. news →

Events

Replays

UroGen Pharma Ltd. (URGN) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 10:00 AM ET
Watch
UroGen Pharma Ltd. (URGN) Q1 2026 Earnings Call
Wed, May 06, 2026 · 10:00 AM ET
Watch
UroGen Pharma Ltd. (URGN) Q4 2025 Earnings Call
Mon, Mar 02, 2026 · 10:00 AM ET
Watch

Research Urogen Pharma Ltd.

Urogen Pharma Ltd. company profile

View the public company page for Urogen Pharma Ltd. on 6ix.

Urogen Pharma Ltd. news

Read company news and market updates connected to Urogen Pharma Ltd..

Urogen Pharma Ltd. investor events

Find investor webinars, events, and replay context for Urogen Pharma Ltd..